CAC
Cowen and Company Portfolio holdings
AUM
$2.9B
This Quarter Return
+10.52%
1 Year Return
+104.28%
3 Year Return
+119.87%
5 Year Return
+632.2%
10 Year Return
–
AUM
$1.21B
AUM Growth
+$1.21B
(+42%)
Cap. Flow
+$342M
Cap. Flow
% of AUM
28.32%
Top 10 Holdings %
Top 10 Hldgs %
40.06%
Holding
735
New
182
Increased
169
Reduced
183
Closed
147
Top Buys
| 1 |
NVIDIA
NVDA
|
$81.5M |
| 2 |
Protagonist Therapeutics
PTGX
|
$45.8M |
| 3 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
$45.2M |
| 4 |
Tarsus Pharmaceuticals
TARS
|
$36.1M |
| 5 |
PTC Therapeutics
PTCT
|
$32.5M |
Top Sells
| 1 |
Sylvamo
SLVM
|
$99.5M |
| 2 |
KVSC
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
|
$24.5M |
| 3 |
TIOA
Tio Tech A Class A Ordinary Share
TIOA
|
$22.2M |
| 4 |
Immunovant
IMVT
|
$19.4M |
| 5 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$17.6M |
Sector Composition
| 1 | Healthcare | 36.03% |
| 2 | Financials | 28.83% |
| 3 | Technology | 9.92% |
| 4 | Energy | 5.75% |
| 5 | Consumer Discretionary | 4.01% |
